Short Interest in Bavarian Nordic A/S (OTCMKTS:BVNRY) Grows By 109.8%

Bavarian Nordic A/S (OTCMKTS:BVNRY) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 8,600 shares, an increase of 109.8% from the December 15th total of 4,100 shares. Based on an average trading volume of 27,900 shares, the days-to-cover ratio is currently 0.3 days.

Bavarian Nordic A/S Trading Up 2.0 %

OTCMKTS:BVNRY traded up $0.18 on Thursday, reaching $8.95. 7,822 shares of the stock traded hands, compared to its average volume of 8,759. Bavarian Nordic A/S has a 1-year low of $6.86 and a 1-year high of $14.60. The company’s 50 day moving average is $9.05 and its 200-day moving average is $10.10. The firm has a market capitalization of $2.12 billion, a price-to-earnings ratio of 12.96 and a beta of 1.65.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.